Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $2.13 USD
Change Today -0.01 / -0.47%
Volume 377.1K
ATRS On Other Exchanges
Symbol
Exchange
NASDAQ CM
Frankfurt
As of 8:10 PM 07/2/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Thomas J. Garrity

Independent Director, Chairman of Audit Committee and Member of Governance & Nominating Committee, Antares Pharma Inc.
AgeTotal Calculated CompensationThis person is connected to 6 board members in 1 different organizations across 1 different industries.

See Board Relationships
66$177,953

Background*

Mr. Thomas J. Garrity served as Executive Vice President and Chief Financial Officer for PCS Health Systems, from 1994 to 2000. Mr. Garrity played a key role during its subsequent integration with Advance Paradigm, Inc. and became Executive Vice President, Financial Operations for the resultant entity, AdvancePCS. Mr. Garrity held various positions at Eli Lilly and Company, including Director of Public Policy and Planning and Development, Director Corporate, Financial ...

Read Full Background

Corporate Headquarters*

100 Princeton South
Ewing, New Jersey 08628

United States

Phone: 609-359-3020
Fax: --

Board Members Memberships*

2003-Present
Independent Director, Chairman of Audit Committee and Member of Governance & Nominating Committee

Education*

MBA
The University of Chicago
BS
Massachusetts Institute of Technology

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$67,953
Total Calculated Compensation$177,953
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ATRS:US $2.13 USD -0.01

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Vincent A. Forlenza Chairman, Chief Executive Officer, President and Chairman of Executive Committee
Becton, Dickinson and Company
$985.0K
Tony K. Chow Chief Executive Officer, President and Director
Bioject Medical Technologies Inc.
--
Eric M. Green Chief Executive Officer
West Pharmaceutical Services, Inc.
--
F. Michael Ball Chief Executive Officer, Director and Member of Science & Technology Committee
Hospira Inc.
$1.1M
Simon Michel Chief Executive Officer
Ypsomed Holding AG
SFr.516.9K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ANTARES PHARMA INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.